HighQ featured in Sunday Times’ Lloyds SME Export Track 100
February 27, 2018 14:19 ET
|
HighQ
LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- HighQ has again earned distinction in Fast Track’s Sunday Times Lloyds SME Export Track 100, which tracks Britain’s small- and medium-sized private...
ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial
January 08, 2018 08:30 ET
|
ARCA biopharma, Inc.
-------------------------------------------------------------------------------------------------- GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial...
ARCA biopharma Announces Completion of Enrollment for GENETIC-AF Phase 2B Clinical Trial
August 16, 2017 08:30 ET
|
ARCA Biopharma, Inc.
GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial Fibrillation ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018 WESTMINSTER,...
Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis
June 01, 2017 09:05 ET
|
Ocera Therapeutics, Inc.
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., June 01, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), today announced the dosing of the first patients in Part Two of a...
ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10
May 31, 2017 07:00 ET
|
ProQR Therapeutics N.V.
Key Updates ProQR receives Fast Track designation by the U.S. Food and Drug Administration (FDA). Closer interaction with FDA could potentially accelerate the development of QR-110 in patients...
ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
May 15, 2017 08:30 ET
|
ARCA Biopharma, Inc.
WESTMINSTER, Colo., May 15, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
US FDA pathway opens to SCENESSE® following Fast Track designation for treatment of EPP
July 06, 2016 08:00 ET
|
Clinuvel Pharmaceuticals Limited
FDA awards Fast Track Designation¹ to expedite review of SCENESSE® in EPPNDA filing allowed on a rolling basisFDA hosting a Scientific Workshop² on EPP to learn more about disease and drug treatment ...
FDA Grants Fast Track Designation to Cempra for Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia
August 19, 2015 07:00 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
FDA Grants Fast Track Designation to Sucampo's Cobiprostone for Oral Mucositis
May 07, 2015 16:42 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
Three world records set on new Mondo Super X 720 surface at IAAF World Relays
May 27, 2014 14:03 ET
|
Mondo
NASSAU, Bahamas, May 27, 2014 (GLOBE NEWSWIRE) -- Once again, Mondo is the surface of new world records. At the inaugural International Association of Athletics Federation's (IAAF) World Relays last...